The role of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer.
CEA
CEACAM1
cancer
malignancy
metastasis
signaling
tumor
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
09
2023
accepted:
08
11
2023
medline:
11
12
2023
pubmed:
11
12
2023
entrez:
11
12
2023
Statut:
epublish
Résumé
The Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), also known as CD66a, is a member of the immunoglobulin superfamily. CEACAM1 was shown to be a prognostic marker in patients suffering from cancer. In this review, we summarize pre-clinical and clinical evidence linking CEACAM1 to tumorigenicity and cancer progression. Furthermore, we discuss potential CEACAM1-based mechanisms that may affect cancer biology.
Identifiants
pubmed: 38077351
doi: 10.3389/fimmu.2023.1295232
pmc: PMC10704240
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1295232Informations de copyright
Copyright © 2023 Götz, Rueckschloss, Balk, Pfeiffer, Ergün and Kleefeldt.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Immunology. 2023 Feb;168(2):273-289
pubmed: 35470423
Oncol Lett. 2018 Mar;15(3):3496-3503
pubmed: 29467871
Blood. 2005 May 15;105(10):3925-34
pubmed: 15687237
J Histochem Cytochem. 2006 Dec;54(12):1393-9
pubmed: 16924126
Nature. 2015 Jan 15;517(7534):386-90
pubmed: 25363763
J Biol Chem. 2016 Sep 16;291(38):20085-95
pubmed: 27471271
Eur J Immunol. 2013 Sep;43(9):2473-83
pubmed: 23696226
World J Surg. 2011 Oct;35(10):2259-65
pubmed: 21519971
Biochem Biophys Res Commun. 2021 Jan 8;535:99-105
pubmed: 33352461
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):521-6
pubmed: 12522268
Clin Dev Immunol. 2012;2012:290536
pubmed: 22291846
Int J Cancer. 2013 Jul 15;133(2):394-407
pubmed: 23319418
Oncogene. 2007 Apr 26;26(19):2747-58
pubmed: 17057731
Oncotarget. 2020 Jan 28;11(4):429-439
pubmed: 32064046
Eur J Immunol. 2000 Sep;30(9):2593-603
pubmed: 11009093
Transl Oncol. 2020 Dec;13(12):100857
pubmed: 32866936
J Clin Oncol. 2002 May 15;20(10):2530-6
pubmed: 12011132
Immunity. 2006 Nov;25(5):769-81
pubmed: 17081782
Med Mol Morphol. 2017 Mar;50(1):42-51
pubmed: 27464654
Mol Cell. 2000 Feb;5(2):311-20
pubmed: 10882072
Cell Oncol (Dordr). 2016 Aug;39(4):379-88
pubmed: 27240826
Oncoimmunology. 2017 May 16;6(7):e1328336
pubmed: 28811966
J Immunol Res. 2015;2015:902137
pubmed: 26688824
Int J Cancer. 2011 Sep 15;129(6):1351-61
pubmed: 21413011
BMC Cancer. 2013 Jul 25;13:359
pubmed: 23885995
Histochem Cell Biol. 2017 Aug;148(2):117-127
pubmed: 28343238
Mol Cancer. 2008 May 28;7:46
pubmed: 18507857
Cancer. 2005 Jul 15;104(2):354-60
pubmed: 15952183
Nat Rev Clin Oncol. 2020 Jul;17(7):395-417
pubmed: 32203277
Pancreas. 2007 May;34(4):436-43
pubmed: 17446843
Neoplasia. 2014 May;16(5):451-60
pubmed: 24931667
Nat Rev Immunol. 2006 Jun;6(6):433-46
pubmed: 16724098
Oncogene. 2008 Jun 12;27(26):3721-8
pubmed: 18278069
Oncogene. 2006 Sep 7;25(40):5527-36
pubmed: 16619040
Oncogene. 2011 Oct 13;30(41):4275-88
pubmed: 21532628
Cancer Res. 2004 Dec 15;64(24):8932-8
pubmed: 15604255
Nat Commun. 2023 Apr 20;14(1):2275
pubmed: 37080973
PLoS One. 2014 Nov 19;9(11):e113023
pubmed: 25409014
PLoS One. 2014 Apr 18;9(4):e94928
pubmed: 24747429
Exp Hematol Oncol. 2022 Nov 11;11(1):97
pubmed: 36369033
Cancer Res. 2015 May 1;75(9):1897-907
pubmed: 25744717
Oncotarget. 2016 Sep 27;7(39):63730-63746
pubmed: 27572314
J Clin Oncol. 2002 Nov 1;20(21):4279-84
pubmed: 12409325
Head Neck. 2019 Jun;41(6):1615-1621
pubmed: 30582236
Front Immunol. 2023 Feb 14;14:1120331
pubmed: 36865539
Cancer Res. 1997 Jun 15;57(12):2354-7
pubmed: 9192807
Biomark Res. 2023 Mar 9;11(1):28
pubmed: 36890557
Stem Cell Res Ther. 2021 Jan 25;12(1):81
pubmed: 33494834
J Immunol. 2005 Jun 1;174(11):6692-701
pubmed: 15905509
Hepatol Commun. 2018 Sep 25;2(10):1247-1258
pubmed: 30288478
Aging Cell. 2019 Dec;18(6):e13025
pubmed: 31389127
mBio. 2020 Feb 4;11(1):
pubmed: 32019805
Int J Cancer. 2020 Apr 15;146(8):2315-2325
pubmed: 31465112
Cancer Sci. 2022 Sep;113(9):3120-3133
pubmed: 35611462
Am J Pathol. 2004 Nov;165(5):1781-7
pubmed: 15509546
Exp Cell Res. 2013 May 1;319(8):1061-72
pubmed: 23499736
Int J Cancer. 1996 Mar 15;65(6):740-5
pubmed: 8631584
Lung Cancer. 2008 Jun;60(3):426-33
pubmed: 18215438
Cancer Biother Radiopharm. 2020 Apr;35(3):190-198
pubmed: 31928422
Int J Med Sci. 2019 Apr 25;16(4):583-592
pubmed: 31171910
Acta Biochim Biophys Sin (Shanghai). 2015 Oct;47(10):788-94
pubmed: 26341981
Oncogene. 2004 Dec 16;23(58):9306-13
pubmed: 15568039
Eur J Immunol. 1998 Nov;28(11):3664-74
pubmed: 9842909
Cells. 2021 Jul 07;10(7):
pubmed: 34359889
Structure. 2022 May 5;30(5):658-670.e5
pubmed: 35219398
Immunology. 2008 Dec;125(4):535-40
pubmed: 18492055
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S505-14
pubmed: 24390710
J Immunother Cancer. 2020 Mar;8(1):
pubmed: 32221015
Blood. 2009 Jun 25;113(26):6726-36
pubmed: 19273835
PLoS One. 2016 Apr 13;11(4):e0153601
pubmed: 27074014
J Leukoc Biol. 2003 Jul;74(1):126-34
pubmed: 12832451
Oncol Lett. 2018 Aug;16(2):1622-1626
pubmed: 30008845
Histochem Cell Biol. 2016 Dec;146(6):657-671
pubmed: 27695943
Oncol Lett. 2017 Oct;14(4):4758-4766
pubmed: 29085477
Sci Rep. 2019 Sep 3;9(1):12702
pubmed: 31481751
Sci Rep. 2016 Feb 25;6:21972
pubmed: 26911181
Cancer Med. 2019 Sep;8(12):5574-5576
pubmed: 31397113
Dis Markers. 2023 Jan 18;2023:3606362
pubmed: 36712923
Biochem Biophys Res Commun. 2013 Jan 11;430(2):598-603
pubmed: 23219815
Cancers (Basel). 2019 Mar 13;11(3):
pubmed: 30871206
Adv Sci (Weinh). 2022 May;9(16):e2103230
pubmed: 35403834
Infect Immun. 2005 Jul;73(7):4171-9
pubmed: 15972507
Cancer Med. 2017 Apr;6(4):845-856
pubmed: 28332308
Exp Cell Res. 1999 Nov 1;252(2):243-9
pubmed: 11501563
Int J Colorectal Dis. 2007 Aug;22(8):869-74
pubmed: 17143599
Aging (Albany NY). 2020 Feb 21;12(4):3121-3123
pubmed: 32084008
J Immunol. 2004 Mar 15;172(6):3535-43
pubmed: 15004154
J Immunol. 1999 Aug 1;163(3):1363-70
pubmed: 10415036
J Cell Biol. 2009 Nov 16;187(4):569-81
pubmed: 19948503
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10744-8
pubmed: 7504281
Cancer Res. 2012 May 1;72(9):2239-50
pubmed: 22406619
Anticancer Res. 2009 Jan;29(1):249-54
pubmed: 19331157
Front Immunol. 2023 Feb 20;14:1113478
pubmed: 36891299
Cell Mol Life Sci. 2020 May;77(9):1745-1770
pubmed: 31690961
Cancer Chemother Pharmacol. 2015 Feb;75(2):421-30
pubmed: 25547406
Cell Physiol Biochem. 2018;45(4):1631-1640
pubmed: 29486474
J Surg Res. 2017 Dec;220:353-362
pubmed: 29180203
Cancer Prev Res (Phila). 2015 Feb;8(2):111-9
pubmed: 25416410
FASEB J. 2018 Oct;32(10):5612-5625
pubmed: 29746166
Cancer Immunol Immunother. 2010 Feb;59(2):215-30
pubmed: 19633846
Cancer Res. 2004 May 1;64(9):3072-8
pubmed: 15126343
Semin Immunol. 2019 Apr;42:101296
pubmed: 31604530
PLoS One. 2010 Jan 18;5(1):e8747
pubmed: 20090913
Nat Rev Immunol. 2020 Nov;20(11):651-668
pubmed: 32433532
J Clin Invest. 2004 Oct;114(7):944-52
pubmed: 15467833
Cell Death Dis. 2022 Mar 9;13(3):220
pubmed: 35264563
Pathol Res Pract. 2014 Aug;210(8):473-6
pubmed: 24846314
Cancers (Basel). 2021 Aug 28;13(17):
pubmed: 34503172
J Leukoc Biol. 2009 Aug;86(2):205-18
pubmed: 19454653
Gene. 2022 Aug 5;834:146668
pubmed: 35690284
Immunity. 2020 Jan 14;52(1):55-81
pubmed: 31940273
J Immunol. 2008 May 1;180(9):6085-93
pubmed: 18424730
PLoS One. 2013 Sep 11;8(9):e74654
pubmed: 24040308
Oncotarget. 2018 Oct 2;9(77):34459-34470
pubmed: 30349641
Cancer Lett. 2007 Apr 8;248(1):68-80
pubmed: 16822608
Oncoimmunology. 2021 Dec 30;11(1):2008110
pubmed: 35141051
J Biol Chem. 2005 Jan 21;280(3):2361-9
pubmed: 15536067
J Exp Med. 2004 Feb 16;199(4):471-82
pubmed: 14970176
Eur J Immunol. 2005 Jun;35(6):1949-59
pubmed: 15909305
J Immunol. 2002 Mar 15;168(6):2803-10
pubmed: 11884449
J Cell Sci. 2010 Dec 15;123(Pt 24):4221-30
pubmed: 21081647
Transl Cancer Res. 2020 Aug;9(8):4762-4769
pubmed: 35117839
Int Immunopharmacol. 2017 Feb;43:210-218
pubmed: 28038383
Am J Clin Pathol. 2009 Jun;131(6):782-7
pubmed: 19461083
J Immunol. 2002 Feb 1;168(3):1028-35
pubmed: 11801635
Nat Commun. 2015 Feb 18;6:6217
pubmed: 25692415
J Biol Chem. 2006 Dec 22;281(51):39179-93
pubmed: 17071610
J Clin Invest. 2002 Oct;110(7):943-53
pubmed: 12370272
Invest Ophthalmol Vis Sci. 2011 Dec 09;52(13):9368-72
pubmed: 22039239
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jan;31(1):164-6
pubmed: 21269981
Front Mol Biosci. 2021 Jul 23;8:619765
pubmed: 34368221
Cancer Gene Ther. 2022 Nov;29(11):1676-1685
pubmed: 35681020
Front Cell Infect Microbiol. 2021 Jul 15;11:692544
pubmed: 34336716
J Exp Med. 2011 Dec 19;208(13):2633-40
pubmed: 22143889
Front Cell Dev Biol. 2019 Jun 14;7:107
pubmed: 31259172
Int J Cancer. 2020 Jul 15;147(2):575-583
pubmed: 32150281
Clin Chim Acta. 2015 Oct 23;450:277-81
pubmed: 26343926
Clin Cancer Res. 2003 Jun;9(6):2260-6
pubmed: 12796394
Hum Pathol. 2002 Mar;33(3):290-8
pubmed: 11979369
Acta Biochim Biophys Sin (Shanghai). 2017 Aug 1;49(8):737-743
pubmed: 28655144
J Biol Chem. 2021 Nov;297(5):101305
pubmed: 34656562
Mol Pharm. 2020 Dec 7;17(12):4691-4703
pubmed: 33170724
Cell Commun Signal. 2014 Apr 15;12:27
pubmed: 24735478
Pathol Res Pract. 2009;205(7):483-9
pubmed: 19243897
Clin Cancer Res. 2023 May 1;29(9):1794-1806
pubmed: 36716293
Eur Urol. 2010 Apr;57(4):648-54
pubmed: 19487071